BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 16864051)

  • 1. Failure of donor lymphocyte infusion to prevent graft rejection in dogs given DLA-identical marrow after 1 Gy of total body irradiation.
    Baron F; Sandmaier BM; Zellmer E; Sorror M; Storer B; Storb R
    Biol Blood Marrow Transplant; 2006 Aug; 12(8):813-7. PubMed ID: 16864051
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dog leukocyte antigen-haploidentical stem cell allografts after anti-CD44 therapy and nonmyeloablative conditioning in a preclinical canine model.
    Fukuda T; Kerbauy FR; Gooley T; Santos EB; Storb R; Sandmaier BM
    Transplantation; 2006 Aug; 82(3):332-9. PubMed ID: 16906030
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD154 blockade and donor-specific transfusions in DLA-identical marrow transplantation in dogs conditioned with 1-Gy total body irradiation.
    Jochum C; Beste M; Zellmer E; Graves SS; Storb R
    Biol Blood Marrow Transplant; 2007 Feb; 13(2):164-71. PubMed ID: 17241922
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stable mixed hematopoietic chimerism in DLA-identical littermate dogs given sublethal total body irradiation before and pharmacological immunosuppression after marrow transplantation.
    Storb R; Yu C; Wagner JL; Deeg HJ; Nash RA; Kiem HP; Leisenring W; Shulman H
    Blood; 1997 Apr; 89(8):3048-54. PubMed ID: 9108426
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adoptive immunotherapy against allogeneic kidney grafts in dogs with stable hematopoietic trichimerism.
    Graves SS; Hogan WJ; Kuhr C; Diaconescu R; Harkey M; Sale GE; Stone B; Georges GE; Storb R
    Biol Blood Marrow Transplant; 2008 Nov; 14(11):1201-8. PubMed ID: 18940673
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of extending the duration of postgrafting immunosuppression and substituting granulocyte-colony-stimulating factor-mobilized peripheral blood mononuclear cells for marrow in allogeneic engraftment in a nonmyeloablative canine transplantation model.
    Zaucha JM; Yu C; Zellmer E; Takatu A; Junghanss C; Little MT; Storb R
    Biol Blood Marrow Transplant; 2001; 7(9):513-6. PubMed ID: 11669218
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Renal allograft tolerance in DLA-identical and haploidentical dogs after nonmyeloablative conditioning and transient immunosuppression with cyclosporine and mycophenolate mofetil.
    Niemeyer GP; Welch JA; Tillson M; Brawner W; Rynders P; Goodman S; Dufresne M; Dennis J; Lothrop CD
    Transplant Proc; 2005 Dec; 37(10):4579-86. PubMed ID: 16387175
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Postgrafting immunosuppression with sirolimus and cyclosporine facilitates stable mixed hematopoietic chimerism in dogs given sublethal total body irradiation before marrow transplantation from DLA-identical littermates.
    Hogan WJ; Little MT; Zellmer E; Friedetzky A; Diaconescu R; Gisburne S; Lee R; Kuhr C; Storb R
    Biol Blood Marrow Transplant; 2003 Aug; 9(8):489-95. PubMed ID: 12931117
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adoptive immunotherapy to increase the level of donor hematopoietic chimerism after nonmyeloablative marrow transplantation for severe canine hereditary hemolytic anemia.
    Takatu A; Nash RA; Zaucha JM; Little MT; Georges GE; Sale GE; Zellmer E; Kuhr CS; Lothrop CD; Storb R
    Biol Blood Marrow Transplant; 2003 Nov; 9(11):674-82. PubMed ID: 14652850
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stable mixed hematopoietic chimerism in dog leukocyte antigen-identical littermate dogs given lymph node irradiation before and pharmacologic immunosuppression after marrow transplantation.
    Storb R; Yu C; Barnett T; Wagner JL; Deeg HJ; Nash RA; Kiem HP; McSweeney P; Seidel K; Georges G; Zaucha JM
    Blood; 1999 Aug; 94(3):1131-6. PubMed ID: 10419907
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hematopoietic chimerism induces renal and skin allograft tolerance in DLA-identical dogs.
    Tillson M; Niemeyer GP; Welch JA; Brawner W; Swaim SF; Rynders P; Lenz SD; Dean B; Lothrop CD
    Exp Hematol; 2006 Dec; 34(12):1759-70. PubMed ID: 17157174
    [TBL] [Abstract][Full Text] [Related]  

  • 12. G-CSF-mobilized peripheral blood mononuclear cells added to marrow facilitates engraftment in nonmyeloablated canine recipients: CD3 cells are required.
    Zaucha JM; Zellmer E; Georges G; Little MT; Storb R; Storer B; Torok-Storb B
    Biol Blood Marrow Transplant; 2001; 7(11):613-9. PubMed ID: 11760149
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intensified postgrafting immunosuppression failed to assure long-term engraftment of dog leukocyte antigen-identical canine marrow grafts after 1 gray total body irradiation.
    Sorror ML; Leisenring W; Mielcarek M; Baron F; Diaconescu R; Hogan WJ; Graves SS; Storb R
    Transplantation; 2008 Apr; 85(7):1023-9. PubMed ID: 18408584
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IL-2 does not enhance the conversion to complete donor chimerism following nonmyeloablative hematopoietic cell transplantation in dogs.
    Georges GE; Storb R; Maciej Zaucha J; Taranova AG; Gooley T; Nash RA
    Bone Marrow Transplant; 2003 Jun; 31(11):1027-31. PubMed ID: 12774055
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stable mixed hematopoietic chimerism in dogs given donor antigen, CTLA4Ig, and 100 cGy total body irradiation before and pharmacologic immunosuppression after marrow transplant.
    Storb R; Yu C; Zaucha JM; Deeg HJ; Georges G; Kiem HP; Nash RA; McSweeney PA; Wagner JL
    Blood; 1999 Oct; 94(7):2523-9. PubMed ID: 10498626
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low Radiation Dose and Low Cell Dose Increase the Risk of Graft Rejection in a Canine Hematopoietic Stem Cell Transplantation Model.
    Lange S; Steder A; Glass Ä; Killian D; Wittmann S; Machka C; Werner J; Schäfer S; Roolf C; Junghanss C
    Biol Blood Marrow Transplant; 2016 Apr; 22(4):637-643. PubMed ID: 26802322
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Canine bone marrow-derived mesenchymal stromal cells suppress alloreactive lymphocyte proliferation in vitro but fail to enhance engraftment in canine bone marrow transplantation.
    Lee WS; Suzuki Y; Graves SS; Iwata M; Venkataraman GM; Mielcarek M; Peterson LJ; Ikehara S; Torok-Storb B; Storb R
    Biol Blood Marrow Transplant; 2011 Apr; 17(4):465-75. PubMed ID: 20457265
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term tolerance to kidney allografts after induced rejection of donor hematopoietic chimerism in a preclinical canine model.
    Graves SS; Mathes DW; Georges GE; Kuhr CS; Chang J; Butts TM; Storb R
    Transplantation; 2012 Sep; 94(6):562-8. PubMed ID: 22929594
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stable trichimerism after marrow grafting from 2 DLA-identical canine donors and nonmyeloablative conditioning.
    Graves SS; Hogan W; Kuhr CS; Diaconescu R; Harkey MA; Georges GE; Sale GE; Zellmer E; Baran SW; Jochum C; Stone B; Storb R
    Blood; 2007 Jul; 110(1):418-23. PubMed ID: 17369487
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Investigation of immunological approaches to enhance engraftment in a 1 Gy TBI canine hematopoietic stem cell transplantation model.
    Lange S; Altmann S; Brandt B; Adam C; Riebau F; Vogel H; Weirich V; Hilgendorf I; Storb R; Freund M; Junghanss C
    Exp Hematol; 2009 Jan; 37(1):143-50. PubMed ID: 19100524
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.